# Developing Artificial Intelligence-based Algorism to Predict Side Effects and Symptoms From Chemotherapy

> **NCT05937477** · — · RECRUITING · sponsor: **Sehhoon Park** · enrollment: 500 (estimated)

## Conditions studied

- Lung Cancer
- Head and Neck Cancer
- Esophageal Cancer

## Interventions

- **OTHER:** Fitbit smartwatch

## Key facts

- **NCT ID:** NCT05937477
- **Lead sponsor:** Sehhoon Park
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-08
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2023-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05937477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05937477, "Developing Artificial Intelligence-based Algorism to Predict Side Effects and Symptoms From Chemotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05937477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*